156 related articles for article (PubMed ID: 30730125)
1. Aflibercept: osteonecrosis of the jaw: Watch out for high-risk situations.
Prescrire Int; 2016 Nov; 25(176):271. PubMed ID: 30730125
[No Abstract] [Full Text] [Related]
2. [Not Available].
Ruhin B
Rev Stomatol Chir Maxillofac Chir Orale; 2016 Nov; 117(5):363-365. PubMed ID: 27364432
[No Abstract] [Full Text] [Related]
3. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Bamias A; Terpos E; Dimopoulos MA
Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
[No Abstract] [Full Text] [Related]
4. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Aragon-Ching JB; Dahut WL
Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
[No Abstract] [Full Text] [Related]
6. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
7. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
Chang JI; Hazboun RC; Chang TI
J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
[No Abstract] [Full Text] [Related]
8. In reply.
Ruggiero SL; Dodson TB
J Oral Maxillofac Surg; 2014 Dec; 72(12):2381-2. PubMed ID: 25305084
[No Abstract] [Full Text] [Related]
9. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
Schwartz HC
J Oral Maxillofac Surg; 2015 Mar; 73(3):377. PubMed ID: 25683041
[No Abstract] [Full Text] [Related]
10. Reply: To PMID 25234529.
Ruggiero SL
J Oral Maxillofac Surg; 2015 Jul; 73(7):1239-40. PubMed ID: 25913511
[No Abstract] [Full Text] [Related]
11. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
12. C-Terminal Telopeptide—Science or Politics?
Schwartz HC
J Oral Maxillofac Surg; 2015 Jul; 73(7):1239. PubMed ID: 25930959
[No Abstract] [Full Text] [Related]
13. Osteonecrosis of the jaw associated with bisphosphonate therapy.
Wirth SM; Lawson AP; Sutphin SD; Adams VR
Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
[No Abstract] [Full Text] [Related]
14. The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw.
Fantasia JE
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):547-53. PubMed ID: 26515736
[TBL] [Abstract][Full Text] [Related]
15. [Focus: Drug-related osteonecrosis of the jaw].
Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaw.
Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2011; 59(6):410-3. PubMed ID: 22313910
[No Abstract] [Full Text] [Related]
18. Osteonecrosis of the Jaw.
Hamdy RC
J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
[No Abstract] [Full Text] [Related]
19. Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
Carlson ER
Cranio; 2010 Jan; 28(1):1-2. PubMed ID: 20158003
[No Abstract] [Full Text] [Related]
20. Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw.
Sambrook PN
Nat Clin Pract Rheumatol; 2009 Jan; 5(1):6-7. PubMed ID: 19030005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
